Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chiaramonte

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Minerva Medica|July 14, 1983
[Immunologic changes in chronic pancreatitis]G Del Favero, A Meani, F Zaccaria, et al.
Epidemiology and Infection|November 6, 2001
Antibodies to hepatitis A virus in Italian patients with chronic liver diseaseE Sagnelli, G Rossi, N Coppola, et al.
Acta Hepato-Gastroenterologica|December 1, 1977
Comparison between bolus injection and infusion of secretin and pancreozymin in the diagnosis of chronic pancreatic disease (one hour test)R Farini, G Del Favero, M Adorati, et al.
Journal of Viral Hepatitis|September 11, 2004
Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevanceL J Yee, P Kelleher, R D Goldin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2001
Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactionsK F Hoffmann, T C McCarty, D H Segal, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2009
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinomaE G Giannini, G Bodini, M Corbo, et al.
Genes and Immunity|August 29, 2003
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKRS Knapp, L J Yee, A J Frodsham, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2000
Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosisP L Almasio, A Floreani, M Chiaramonte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 14, 2005
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of lifeP Rucci, G Taliani, L Cirrincione, et al.
Oncology|April 15, 1999
Gross pathologic types of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Minerva Medica|July 14, 1983
[Immunologic changes in chronic pancreatitis]G Del Favero, A Meani, F Zaccaria, et al.
Epidemiology and Infection|November 6, 2001
Antibodies to hepatitis A virus in Italian patients with chronic liver diseaseE Sagnelli, G Rossi, N Coppola, et al.
Acta Hepato-Gastroenterologica|December 1, 1977
Comparison between bolus injection and infusion of secretin and pancreozymin in the diagnosis of chronic pancreatic disease (one hour test)R Farini, G Del Favero, M Adorati, et al.
Journal of Viral Hepatitis|September 11, 2004
Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevanceL J Yee, P Kelleher, R D Goldin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2001
Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactionsK F Hoffmann, T C McCarty, D H Segal, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2009
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinomaE G Giannini, G Bodini, M Corbo, et al.
Genes and Immunity|August 29, 2003
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKRS Knapp, L J Yee, A J Frodsham, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2000
Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosisP L Almasio, A Floreani, M Chiaramonte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 14, 2005
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of lifeP Rucci, G Taliani, L Cirrincione, et al.
Oncology|April 15, 1999
Gross pathologic types of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Pageof 14